DROPBOT
LIVE

Serial Number

99127459

Owner

Sci-bots Inc.

Attorney

Danielle Cohen

First Use Date

Nov 6, 2017

Filing Date

Apr 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DROPBOT Trademark

Serial Number: 99127459 • Registration: 8279571

DROPBOT is a trademark filed by Sci-bots Inc. on April 8, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Sci-bots Inc.

277 Richmond St. W.
Toronto, ON M5V 1X1

Entity Type: 03

Trademark Details

Filing Date

April 8, 2025

Registration Date

June 2, 2026

First Use Anywhere

November 6, 2017

First Use in Commerce

November 6, 2017

Published for Opposition

April 14, 2026

Goods & Services

Laboratory, scientific, optical, and electrical research apparatus and instruments, namely, digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for use in automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for biological, genetic, chemical, medical, and scientific research and analysis, power controllers, and sensor chips for laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for sample preparation, manipulation, and analysis in chemical and biochemical workflows for laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for testing and measuring an attribute in assays for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for single-cell and bulk-sample analyses for identifying, isolating, capturing, sorting, imaging, counting, and analyzing cells and tissue for use in the fields of laboratory, scientific, optical and electrical research; Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomarkers, proteins, nucleic acids, metabolites, chemical contaminants and biological contaminants; Scientific apparatus and instruments for creating, analyzing, and manipulating droplets and micro-droplets for the presence, absence, or quantity of biomarkers, proteins, nucleic acids, metabolites, chemical contaminants and biological contaminants; Kits comprising peptide substrates for preparing samples for chemical analysis, biochemical analysis, imaging microfluidic analysis, and digital microfluidic analysis; Data processing equipment for use with apparatus and instruments for creating, analysing and manipulating droplets and micro-droplets; Downloadable software for chemical and biochemical analysis in the field of scientific imaging and microfluidics; Downloadable computer software and embedded firmware for configuring, operating, and analyzing data from digital microfluidic platforms used in chemical, biochemical, and medical assays; Scientific research platform device comprised primarily of computer hardware and also including recorded software for single-cell and bulk-sample analyses for identifying, isolating, capturing, sorting, imaging, counting, and analyzing cells and tissue for use in the fields of laboratory, scientific, optical and electrical research; Scientific research platform device comprised primarily of computer hardware and recorded software for use in automating sample preparation, droplet manipulation, and data analysis in laboratory workflows; Downloadable scientific and medical data for use in chemical analysis, biochemical analysis and microfluidic analysis; Electronic circuit boards for use as controllers for digital microfluidic platform devices; Scientific laboratory research instruments for use with digital microfluidic applications in the field of medical imaging; Microscopes for use with digital microfluidic chips; Integrated digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for sample preparation for use with external analytical instruments, namely, instruments for mass spectrometry, instruments for fluorescence spectroscopy, electrochemical sensors, and nucleic acid sequencing instruments ; Remote controls for digital microfluidic platform devices and sensor chips for digital microfluidic platform devices for scientific use; Automated liquid handling systems comprised primarily of computer hardware, electronic controllers, sensor chips, and recorded computer software for automating sample preparation, droplet manipulation, and fluid dispensing in digital microfluidic workflows, and laboratory consumables, namely, pipette tips for digital microfluidic workflows; Automated liquid handling systems comprised primarily of computer hardware, electronic controllers, sensor chips, and recorded computer software for automating sample preparation, droplet manipulation, and fluid dispensing in digital microfluidic workflows; Computer hardware and downloadable computer software for controlling automated liquid handling systems; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for use in agricultural testing, environmental testing and food testing for laboratory, scientific, optical and electrical research

Medical devices, namely, digital microfluidic platforms for in vitro diagnostic testing of patient samples for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Medical devices, namely, digital microfluidic platforms for sample preparation and analysis in medical and clinical research and for chemical assays, biochemical assays, and clinical diagnostics in laboratory settings for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Digital microfluidic platforms for research use in medical and life sciences applications, for cellular and molecular analysis in research and laboratory settings, and for point-of-care diagnostic testing for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; AI-assisted digital microfluidic platforms for automated biomarker detection for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Apparatus and instruments for droplet chemical and biochemical analysis for medical diagnostic purposes; Laboratory-based instruments and consumables in the nature of digital microfluidic medical analyzers and disposable medical diagnostic cartridges for medical sample preparation and analysis, namely, biomarker detection, cytokine profiling, nucleic acid analysis, and therapeutic drug monitoring for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Digital microfluidic chips for use in medical applications, namely, detecting biomarkers, performing immunoassays, and point-of-care diagnostic tests for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 2, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 2, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 29, 2025 GNFN
FINAL REFUSAL E-MAILED
Dec 29, 2025 GNFR
FINAL REFUSAL WRITTEN
Dec 29, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 8, 2025 MAFR
NEW APPLICATION ENTERED
Apr 8, 2025 NWAP